Showing all 15 results
Abacavir & Lamivudine Tablets.
FreeProduct Composition & Strength
We supply this product in the globally standardized “600/300” ratio, optimized for maximum efficacy with a convenient once-daily dosing schedule.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP 600 mg The Guanosine Analogue: Stops viral DNA synthesis by mimicking the guanosine building block. Lamivudine USP/BP 300 mg The Cytidine Analogue: A highly potent NRTI that works synergistically to block the reverse transcriptase enzyme. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to ensure consistent absorption and protect the APIs from environmental degradation. Abacavir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for both adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP/Ph.Eur. 300 mg The Standard Dose: Usually taken twice daily as part of a multi-drug regimen. Abacavir (as Sulfate) USP/BP/Ph.Eur. 600 mg The Once-Daily Anchor: Optimized for patient compliance in simplified treatment schedules. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and protect the API from environmental degradation. Aciclovir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to cover everything from simple cold sores to severe shingles cases.
Active Ingredient Strength Primary Clinical Function Aciclovir USP/BP/Ph.Eur. 200 mg The Herpes Unit: Standard dose for the treatment and suppression of Herpes Simplex (HSV-1 and HSV-2). Aciclovir USP/BP/Ph.Eur. 400 mg The Prophylactic Anchor: Used for long-term suppression in immunocompromised patients. Aciclovir USP/BP/Ph.Eur. 800 mg The Zoster Payload: High-potency dose required to treat Shingles (Herpes Zoster) and Chickenpox. Aminosalicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Delayed-Release (DR) Tablet, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function 4-Aminosalicylic Acid USP/BP 500 mg The Standard Titration Unit: Allows for gradual dose escalation to manage gastrointestinal side effects. 4-Aminosalicylic Acid USP/BP 1000 mg The Maintenance Payload: High-dose format for adult MDR-TB regimens requiring up to 8–12g daily. Excipients Acid-Resistant Polymer Enteric Shield System: Engineered to bypass the stomach and release the API in the upper intestine for maximum absorption. Atazanavir & Ritonavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour viral suppression.
Active Ingredient Strength Primary Clinical Function Atazanavir (as Sulfate) USP/BP 300 mg The Antiviral Anchor: Blocks the maturation of HIV, preventing the spread of infection to CD4 cells. Ritonavir USP/BP 100 mg The Pharmacokinetic Booster: Inhibits liver metabolism to maintain high Atazanavir levels for 24 hours. Excipients Proprietary Matrix Bio-Enhancement System: Engineered to ensure maximum intestinal absorption, which is critical for PI-class medications. Azithromycin & Cefixime tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to prevent the degradation of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/BP 200 mg The Gram-Negative Specialist: Targets the cell walls of stubborn bacteria, highly effective in Typhoid and Bronchitis. Azithromycin (as Dihydrate) USP/BP 250 mg / 500 mg The Tissue-Penetrating Anchor: Provides prolonged activity in the lungs and soft tissues to eliminate intracellular pathogens. Excipients Proprietary Matrix Dual-Release System: Engineered to ensure synchronized absorption of both antibiotics despite their different chemical solubilities. Daclatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dihydrochloride Salt Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the active virological agent.
Active Ingredient Strength Primary Clinical Function Daclatasvir Dihydrochloride USP/Ph.Eur. 60 mg The Standard Eradication Macrodose: The definitive, globally standardized daily therapeutic payload utilized for the vast majority of patients to achieve a Sustained Virologic Response (SVR12 – Clinical Cure). Daclatasvir Dihydrochloride USP/Ph.Eur. 30 mg The CYP3A4 Titration Unit: The strict, mandatory dose-reduction unit utilized for patients who are co-infected with HIV and taking strong CYP3A inhibitors (like Ritonavir or Atazanavir). Excipients Anhydrous Lactose / Microcrystalline Cellulose / Croscarmellose Sodium / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film (Opadry Green) Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced dissolution-enhancing matrices to ensure the Dihydrochloride salt separates perfectly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Heavy-Gauge HDPE Bottles of 28 (Optimized exactly for a 4-week supply in strict 12-week or 24-week curative regimens).
Diphenoxylate & Atropine Sulfate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both the opioid and the anticholinergic alkaloid.
Active Ingredient Strength Primary Clinical Function Diphenoxylate Hydrochloride USP/Ph.Eur. 2.5 mg The Anti-Diarrheal Anchor: The potent mu-opioid agonist required to physically halt hyperactive intestinal peristalsis. Atropine Sulfate USP/Ph.Eur. 0.025 mg (25 mcg) The Abuse Deterrent (Ultra-Microdose): The anticholinergic alkaloid engineered strictly to prevent deliberate opioid overdosage. Excipients Microcrystalline Cellulose / Sucrose / Maize Starch / Magnesium Stearate / Purified Talc Diluent / Binder / Disintegrant / Lubricant / Glidant (Engineered utilizing Extreme Multi-Stage Geometric Dilution to guarantee the microscopic 25 microgram Atropine payload is flawlessly distributed throughout the tablet, preventing lethal anticholinergic “hot spots”) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute gastrointestinal dispensing regimens).
Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
Ledipasvir & Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
Norfloxacin & Tinidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Norfloxacin USP/Ph.Eur. 400 mg Aerobic Gut/UTI Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Tinidazole USP/Ph.Eur. 600 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and pelvic anaerobes. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute anti-infective dispensing regimens).
Ofloxacin & Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Aerobic Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Ornidazole INN/Ph.Eur. 500 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and surgical-site anaerobes. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-5 day acute anti-infective dispensing regimens).
